Guoqian Venture Capital

Jiangsu Junhua is an engineering plastics manufacturer specializing in the research and development of high-performance special engineering plastic parts and profiles like PEEK and PI.

Insaifeiying is a manufacturer of innovative medical equipment for minimally invasive surgery. It focuses on the research, development, and manufacturing of intelligent wireless endoscopes.

Yunmao Technology is a manufacturing enterprise specializing in nano-equipment, specifically designed for the semiconductor and new energy sectors. The company offers advanced equipment and services for ultra-high vacuum coating, atomic layer deposition (ALD), physical vapor deposition (PVD), and ion beam etching (IBE). Their solutions cater to the production needs of chips, semiconductors, and lithium batteries, enabling clients to achieve high-quality nano thin film deposition. By focusing on nanotechnology, Yunmao Technology supports innovation and efficiency in various high-tech applications.

Bioantibody is a biotechnology firm focused on the research and development of antigens, antibodies, and detection reagents for diagnostic and therapeutic applications. The company specializes in producing core raw materials for in vitro diagnostics and biopharmaceuticals, utilizing advanced targeted hybridoma cell fusion technology. This technology is complemented by stable cell growth factors and high-throughput screening methods, addressing a wide range of medical categories, including cardiovascular, cerebrovascular, inflammation, infectious diseases, tumors, and hormones. By offering high-quality raw materials, Bioantibody aims to enhance disease detection and improve therapeutic outcomes for its customers.

Baikang Bio is a tech biotechnology firm specializing in the research and development of antigens, antibodies, and downstream detection reagents for diagnosis and therapy. The product pipelines cover cardiovascular and cerebrovascular, inflammation, infectious diseases, tumors, hormones, and other categories, from raw materials to finished goods. They are dedicated to innovation and providing their customers with solutions. They could contribute to human ecology and health.

Leanstar Sensor has developed the core design capabilities of multi-variety and multi-range flexible micro-nano mechanical force sensors. Their products are flexible pressure sensors, flexible piezoelectric sensors, flexible capacitive sensors, flexible thermal sensors, flexible temperature and humidity sensors, and flexible integrated composite micro-nano sensors.

Keyto specializes in the production of key electrical and mechanical components for microfluid system controls.

Suzhou Xinqing Medical Technology Co., Ltd., founded in 2017 by Dr. Xu Bozhen, focuses on the development of in-vitro artificial heart devices aimed at assisting patients with cardiovascular illnesses. The company specializes in creating short-term to medium-term ventricular assist devices that leverage advanced fluid mechanics and magnetic suspension technology. These innovations allow the devices to be compatible with various blood types, thereby reducing the risk of incompatibility for patients. With a team of leading experts in artificial heart engineering, the company has successfully developed an artificial heart that holds independent intellectual property rights, positioning itself as a key player in the medical technology sector.

Dima Biotech is a tumor immunotherapy and monoclonal antibody developer, specializing in the development of recombinant monoclonal antibodies for tumor immune products and services. It has the unique RECmAb digital monoclonal antibody technology, which can be used to obtain a variety of genus and high quality. Monoclonal antibodies.

Suzhou Xinqing Medical Technology Co., Ltd., founded in 2017 by Dr. Xu Bozhen, focuses on the development of in-vitro artificial heart devices aimed at assisting patients with cardiovascular illnesses. The company specializes in creating short-term to medium-term ventricular assist devices that leverage advanced fluid mechanics and magnetic suspension technology. These innovations allow the devices to be compatible with various blood types, thereby reducing the risk of incompatibility for patients. With a team of leading experts in artificial heart engineering, the company has successfully developed an artificial heart that holds independent intellectual property rights, positioning itself as a key player in the medical technology sector.

Guoke Junhao is a POCT medical device and diagnostic reagent research and development distributor, focusing on the field of chemiluminescence immunoassay, mainly developing small automatic microfluidic immunoassay analyzer, which can realize inspection automation, fast and efficient, low cost, simple operation, etc.

EYESEE is a provider of ophthalmology services, specializing in eye screening and eye care for children, teens, and adults. The company operates a chain of clinics that offer vision screening and behavioral awareness education. EYESEE has developed a myopia prevention and control strategy tailored to individual needs, establishing eye health records for students and utilizing advanced analytics to predict the onset and progression of myopia in young populations. Additionally, the company has created an artificial intelligence system designed to enhance visual acuity screening, further supporting its mission to improve eye health across various demographics.

APOLLOMICS is a biotechnology company that develops domestic clinical testing reagents and provides disease testing services.